Lifevantage (LFVN)
Nasdaq Market Closed
LifeVantage Corporation is a wellness and personal care company that develops and distributes nutraceutical supplements, skincare products, energy products, and weight management offerings. The company focuses on products marketed around healthy aging, cellular wellness, and daily lifestyle support, with brands that include Protandim, TrueScience, Axio, and PhysIQ.
Protandim is one of LifeVantage’s core supplement lines and is positioned around the company’s interest in oxidative stress and cellular health. TrueScience covers skincare and personal care products, while Axio includes energy drink mixes. PhysIQ and related offerings address weight management and general wellness. The company’s portfolio places it within the broader direct-to-consumer health and wellness market, where brand loyalty, product differentiation, and distributor engagement are important competitive factors.
LifeVantage uses a direct selling model, relying on independent consultants or distributors to market products to customers. This approach gives the company an international sales network without the same retail footprint required by traditional consumer goods companies, but it also makes distributor productivity, retention, and regulatory compliance important parts of the business.
The company sells products in multiple markets, including the United States, Japan, Hong Kong, Australia, Canada, the Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands. Its geographic spread gives it exposure to global demand for wellness products, though sales performance can vary by market depending on consumer preferences, currency movements, and local regulations.
As a publicly traded company, LifeVantage is associated with the nutraceutical and anti-aging categories rather than pharmaceutical healthcare. Its distinctive position comes from combining branded wellness products with a network-based distribution structure and a product strategy centered on supplements, skincare, energy, and weight management.
Last updated
- Market Cap
- 104.96M
- P/E
- 18.25
- P/FCF
- 27.8
- P/S
- 0.54
- Enterprise Value
- 92.48M
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Address
- 3300 TRIUMPH BLVD, LEHI, UT, 84043
LifeVantage Announces Acquisition of LoveBiome, Expanding Leadership in Direct Sales, Microbiome Health and Wellness
LifeVantage Introduces the MindBody GLP-1 System™ Transforming Weight Management into a Sustainable Lifestyle
LifeVantage To Participate in Upcoming Investor Conferences
LifeVantage Declares Quarterly Dividend
LifeVantage to Announce Third Quarter Fiscal Year 2024 Results on May 2, 2024
LifeVantage Wraps Up Momentum Academy 2024 with a Focus on Entrepreneurship and Growth
LifeVantage Transforms the Future of Skin Health and Radiance: Introducing the TrueScience® Activated Skin Care Collection
LifeVantage to Participate in the Winter Wrap Up MicroCap Rodeo Conference
LifeVantage Appoints Dayton Judd to the Board of Directors
LifeVantage Declares Quarterly Dividend
LifeVantage Announces Financial Results for the Second Quarter of Fiscal 2024
LifeVantage to Announce Second Quarter Fiscal Year 2024 Results on January 30, 2024
LifeVantage Corporation to Participate in Water Tower Fireside Chat Series
LifeVantage® Study Reveals Synergistic Effects of Protandim® Nrf2 Synergizer® and TrueScience® Liquid Collagen
LifeVantage Appoints Raymond Greer as Chairman of the Board of Directors
Stockholders Re-Elect All Seven LifeVantage Incumbent Directors at Fiscal Year 2024 Annual Meeting
LifeVantage Declares Quarterly Dividend
LifeVantage® Introduces TrueScience® TrueRenew Daily Firming Complex, A Better-than-Cosmetic Retinol Alternative
LifeVantage Responds to Radoff-Sudbury Group’s False Allegations
LifeVantage Sends Letter and Stock Chart to Stockholders Highlighting Stock Outperformance in 2023
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 104.96M
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 92.48M
- P/E
P/E ratio compares a company's share price to its earnings per share.
- 18.25
- P/B
P/B ratio compares a company's share price to its book value per share.
- 3.15
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 0.54
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- 9.83
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 0.47
- EPS
- 0.46
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 2.17%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- 27.8
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- 16.13
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- 3.78M
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- 17.25%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- 9.26%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 1.96
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 1.04
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.62
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 436.92K
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 8.32
Income Statement
| Line Item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Revenue | 43.72M | 48.93M | 47.56M | 55.11M | 58.44M |
| Gross profit | 34.54M | 36.21M | 37.82M | 44.05M | 47.33M |
| Operating income | 1.68M | 487K | 2.27M | 2.15M | 4.05M |
| EBITDA | 2.39M | 1.24M | 2.88M | 2.9M | 4.86M |
| Net income | 1.36M | 276K | 2.16M | 1.96M | 3.47M |
| Basic EPS | 0.11 | 0.02 | 0.17 | 0.16 | 0.28 |
| Diluted EPS | 0.11 | 0.02 | 0.17 | 0.15 | 0.26 |
Balance Sheet
| Line Item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total assets | 62.13M | 61.17M | 61.58M | 71.96M | 77.24M |
| Total liabilities | 28.79M | 28.18M | 28.42M | 37.32M | 43.23M |
| Total equity | 33.34M | 32.99M | 33.16M | 34.64M | 34.01M |
| Cash & equivalents | 12.48M | 10.18M | 13.09M | 20.2M | 22.47M |
| Current assets | 39.31M | 38.56M | 45.05M | 50.89M | 54.11M |
| Current liabilities | 20.1M | 19.01M | 18.83M | 27.22M | 32.58M |
Cash Flow
| Line Item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Operating cash flow | 4.99M | 2.79M | -2.31M | 1.03M | 2.23M |
| Investing cash flow | -1.01M | -4.83M | -439K | -199K | -331K |
| Financing cash flow | -1.6M | -738K | -4.3M | -3.24M | -1.13M |
| Change in cash | 2.3M | -2.91M | -7.11M | -2.27M | 874K |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 10-Q — Lifevantage Corp | View Filing | |
| edgar index | 8-K — Lifevantage Corp | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — Lifevantage Corp | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — Lifevantage Corp | View Filing | |
| edgar index | 4 — Lifevantage Corp | View Filing | |
| edgar index | 4 — Lifevantage Corp | View Filing | |
| edgar index | 4 — Lifevantage Corp | View Filing | |
| edgar index | SCHEDULE 13G/A — Lifevantage Corp | View Filing | |
| form 4 | Form 4 — Cunningham Kristen | View Filing | |
| form 4 | Form 4 — Fife Steven R | View Filing | |
| form 4 | Form 4 — Aure Carl | View Filing | |
| form 4 | Form 4 — Neufeld Alissa | View Filing | |
| edgar index | EFFECT — Lifevantage Corp | View Filing | |
| edgar index | CORRESP — Lifevantage Corp | View Filing | |
| edgar index | 4 — Lifevantage Corp | View Filing | |
| edgar index | UPLOAD — Lifevantage Corp | View Filing | |
| form 4 | Form 4 — Lewis Darwin | View Filing | |
| edgar index | S-3 — Lifevantage Corp | View Filing | |
| edgar index | 4 — Lifevantage Corp | View Filing | |
| form 4 | Form 4 — Dayton Judd | View Filing | |
| form 4 | Form 4 — Dayton Judd | View Filing | |
| form 4 | Form 4 — Dayton Judd | View Filing | |
| form 4 | Form 4 — Dayton Judd | View Filing | |
| edgar index | 4 — Lifevantage Corp | View Filing | |
| form 4 | Form 4 — Lewis Darwin | View Filing | |
| edgar index | 10-Q — Lifevantage Corp | View Filing | |
| edgar index | 8-K — Lifevantage Corp | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — Lifevantage Corp | View Filing | |
| edgar index | 4 — Lifevantage Corp | View Filing | |
| edgar index | 4 — Lifevantage Corp | View Filing | |
| edgar index | 4 — Lifevantage Corp | View Filing | |
| form 4 | Form 4 — Aure Carl | View Filing | |
| form 4 | Form 4 — Fife Steven R | View Filing | |
| form 4 | Form 4 — Neufeld Alissa | View Filing | |
| form 4 | Form 4 — Cunningham Kristen | View Filing | |
| edgar index | 4 — Lifevantage Corp | View Filing | |
| form 4 | Form 4 — Thompson Todd | View Filing | |
| edgar index | 4 — Lifevantage Corp | View Filing | |
| edgar index | 4 — Lifevantage Corp | View Filing | |
| form 4 | Form 4 — Lewis Darwin | View Filing | |
| edgar index | 8-K — Lifevantage Corp | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — BEINDORFF MICHAEL A | View Filing | |
| form 4 | Form 4 — BEINDORFF MICHAEL A | View Filing | |
| form 4 | Form 4 — BEINDORFF MICHAEL A | View Filing | |
| form 4 | Form 4 — BEINDORFF MICHAEL A | View Filing | |
| edgar index | 4 — Lifevantage Corp | View Filing | |
| form 4 | Form 4 — BEINDORFF MICHAEL A | View Filing | |
| form 4 | Form 4 — BEINDORFF MICHAEL A | View Filing | |
| form 4 | Form 4 — BEINDORFF MICHAEL A | View Filing | |
| form 4 | Form 4 — BEINDORFF MICHAEL A | View Filing | |
| edgar index | S-8 — Lifevantage Corp | View Filing | |
| edgar index | 8-K — Lifevantage Corp | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — Lifevantage Corp | View Filing | |
| edgar index | 4 — Lifevantage Corp | View Filing | |
| edgar index | 4 — Lifevantage Corp | View Filing | |
| edgar index | 4 — Lifevantage Corp | View Filing | |
| edgar index | 4 — Lifevantage Corp | View Filing | |
| edgar index | 4 — Lifevantage Corp | View Filing | |
| edgar index | 144 — Lifevantage Corp | View Filing | |
| form 4 | Form 4 — BEINDORFF MICHAEL A | View Filing | |
| form 4 | Form 4 — BEINDORFF MICHAEL A | View Filing | |
| form 4 | Form 4 — Lewis Darwin | View Filing | |
| form 4 | Form 4 — Dayton Judd | View Filing | |
| form 4 | Form 4 — Dayton Judd | View Filing | |
| form 4 | Form 4 — BEINDORFF MICHAEL A | View Filing | |
| form 4 | Form 4 — BEINDORFF MICHAEL A | View Filing | |
| form 4 | Form 4 — BEINDORFF MICHAEL A | View Filing | |
| form 4 | Form 4 — Greer Raymond B | View Filing | |
| form 4 | Form 4 — Latham Cynthia | View Filing | |
| form 4 | Form 4 — Anbalagan Rajendran | View Filing |